Oct-2 is a transcription factor belonging to the POU homeo-domain family that binds to the Ig gene octamer sites regulating B cell specific genes. It is dependent on the activity of B cell restricted coactivators such as BOB.1/OBF.1. Oct-2 protein expression is not restricted to B cells, although expression levels are much higher in these cells. Reports indicate that germinal center B cells shows higher expression for Oct-2 and BOB.1/OBF.1. In addition, Oct-2 expression is reported to be significantly greater in germinal center derived lymphomas, although other B cell lymphomas also display high levels of expression. Reed Sternberg (RS) cells represent the malignant cells in classical Hodgkin's disease and are derived from germinal center B cells. In a number of these cases, cells do not express immunoglobulin due to the presence of crippling mutations within the Ig genes. As Ig gene expression in B cells also requires an interaction between octamer sites and the transactivating factors Oct-2 and BOB.1, the absence of both Oct-2 and BOB.1 expression represents a novel mechanism for immunoglobulin gene deregulation in RS cells.
|PA0532||7ml Oct-2 Bond RTU Primary||Bond ready to use reagent||P(HIER)||Info||MSDS||1|
|OCT2-CE||1ml NCL-OCT2||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|
|OCT2||1ml NCL-OCT2||Lyophilised Concentrated Monoclonal Antibody||F, P(HIER)||Info||MSDS||1|
|OCT2-CE-S||0.1ml NCL-OCT2-S||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|
|OCT2-S||0.1ml NCL-OCT2-S||Lyophilised Concentrated Monoclonal Antibody||F, P(HIER)||Info||MSDS||1|